Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 15470214

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2004 Oct 7
First author
Petrylak DP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2004 Oct 7;351(15):1488-90. doi: 10.1056/NEJMp048178.
    note
    Source null
    related pmid
    15470210
    relationship
    Comment in
  2. citation
    N Engl J Med. 2005 Jan 13;352(2):200-1; author reply 200-1. doi: 10.1056/NEJM200501133520218.
    note
    Source null
    related pmid
    15647586
    relationship
    Comment in
  3. citation
    Curr Oncol Rep. 2005 May;7(3):205-6. doi: 10.1007/s11912-005-0074-1.
    note
    Source null
    related pmid
    15847711
    relationship
    Comment in

Authors and identifiers

  1. name
    Petrylak DP
    type
    Author
  2. name
    Tangen CM
    type
    Author
  3. name
    Hussain MH
    type
    Author
  4. name
    Lara PN Jr
    type
    Author
  5. name
    Jones JA
    type
    Author
  6. name
    Taplin ME
    type
    Author
  7. name
    Burch PA
    type
    Author
  8. name
    Berry D
    type
    Author
  9. name
    Moinpour C
    type
    Author
  10. name
    Kohli M
    type
    Author
  11. name
    Benson MC
    type
    Author
  12. name
    Small EJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Petrylak DP
    type
    Author
  2. name
    Tangen CM
    type
    Author
  3. name
    Hussain MH
    type
    Author
  4. name
    Lara PN Jr
    type
    Author
  5. name
    Jones JA
    type
    Author
  6. name
    Taplin ME
    type
    Author
  7. name
    Burch PA
    type
    Author
  8. name
    Berry D
    type
    Author
  9. name
    Moinpour C
    type
    Author
  10. name
    Kohli M
    type
    Author
  11. name
    Benson MC
    type
    Author
  12. name
    Small EJ
    type
    Author
bibliography ids
  1. nci-bib-4258bbe0f79762424233533f
book metadata
content sha256
59a7a349d76d9923c5bcb895fcdd9bc96064fbd031ea855d55e6fee17df8df4e
document type
citation
dois
  1. 10.1056/NEJMoa041318
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:15470214
immutable id
pubmed:15470214@59a7a349d76d9923c5bcb895fcdd9bc96064fbd031ea855d55e6fee17df8df4e
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
15
name
The New England journal of medicine
nlm unique id
0255562
pages
1513-20
volume
351
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2004 Oct 7;351(15):1488-90. doi: 10.1056/NEJMp048178.
    note
    Source null
    related pmid
    15470210
    relationship
    Comment in
  2. citation
    N Engl J Med. 2005 Jan 13;352(2):200-1; author reply 200-1. doi: 10.1056/NEJM200501133520218.
    note
    Source null
    related pmid
    15647586
    relationship
    Comment in
  3. citation
    Curr Oncol Rep. 2005 May;7(3):205-6. doi: 10.1007/s11912-005-0074-1.
    note
    Source null
    related pmid
    15847711
    relationship
    Comment in
outcomes validated
false
pmid
15470214
provenance
batch id
97b9e848a139d5f8d462
provider
NCBI PubMed ESummary
record sha256
d0c7aacc61a9de864424a50ba42dc2e5f38f345b95379e751db939922dcfb172
response sha256
a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
retrieved at
2026-09-09T23:45:57.930512+00:00
publication date
display
2004 Oct 7
precision
day
year
2004
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase III
  3. Comparative Study
  4. Journal Article
  5. Multicenter Study
  6. Randomized Controlled Trial
  7. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/15470214/
title
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

Preserved source evidence · Not medical advice